Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000464447 | SCV000391310 | benign | Hereditary spastic paraplegia 11 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000464447 | SCV000557276 | benign | Hereditary spastic paraplegia 11 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001579839 | SCV001906492 | benign | not provided | 2019-05-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31182772) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001700053 | SCV002104003 | likely benign | not specified | 2022-02-18 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848657 | SCV002105787 | benign | Hereditary spastic paraplegia | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002467748 | SCV002764199 | likely benign | Amyotrophic lateral sclerosis type 5 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467749 | SCV002764200 | likely benign | Charcot-Marie-Tooth disease axonal type 2X | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV000464447 | SCV002764201 | likely benign | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing | ||
Prevention |
RCV003930356 | SCV004743401 | benign | SPG11-related condition | 2019-10-22 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Yunnan Provincial Key Laboratory of Clinical Virology, |
RCV000464447 | SCV001573722 | affects | Hereditary spastic paraplegia 11 | no assertion criteria provided | research | ||
Genome Diagnostics Laboratory, |
RCV001579839 | SCV001808680 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700053 | SCV001917210 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001579839 | SCV001927257 | likely benign | not provided | no assertion criteria provided | clinical testing |